Product overview

Name LY 333531 hydrochloride
Alternative names Ruboxistaurin
Description Potent, selective, competitive PKC inhibitor
Write Your Own Review
You're reviewing:LY 333531 hydrochloride
Rate this item:

Biological Data

Biological description Potent, selective and competitive protein kinase C (PKC) inhibitor. Selective for PKCβI and PKCβII (IC50 values are 4.7 and 5.9 nM respectively) over PKCα by 76- and 61- fold respectively. Shows antinociceptive actions against and improves vascular function in diabetes.

Solubility & Handling

Storage instructions -20°C
Solubility overview Soluble in DMSO (20mM)
Important This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use.

Calculators

Molarity

=
x
x
More Info

Dilution

x
=
x
More Info

Chemical Data

Chemical name (9S)-9-[(Dimethylamino)methyl]-6,7, 10,11-tetrahydro-9H,18H-5,21:12,17-dimethenodibenz o[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecin e-18,20(19H)-dione hydrochloride
Molecular Weight 505.01
Chemical structure LY 333531 hydrochloride  [169939-93-9] Chemical Structure
Molecular Formula C28H28N4O3.HCl
CAS Number 169939-93-9
PubChem identifier 9870785
SMILES O=C(C(C4=CN(CCO[C@H](CN(C)C)CC6)C5=C4C=CC=C5)=C1C2=CN6C3=CC=CC=C23)NC1=O.Cl
InChiKey NYQIEYDJYFVLPO-FERBBOLQSA-N

References for LY 333531 hydrochloride

References are publications that support the biological activity of the product
  • Protein kinase Cbeta selective inhibitor LY333531 attenuates diabetic hyperalgesia through ameliorating cGMP level of dorsal root ganglion neurons.

    Kim H et al (2003) Diabetes 52(8) : 2102-9.
  • Effects of the protein kinase C beta inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes.

    Cotter MA et al (2002) Clin Sci (Lond) 103(3) : 311-21.
  • (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta.

    Jirousek MR et al (1996) J Med Chem 39(14) : 2664-71.

3 Item(s)